Troyanova Transpleural Access

Troyanov transpleural access: history and application

Troyanov transpleural access is a method of surgical intervention that was developed by A.A. Troyanov at the beginning of the 20th century. This method involves accessing the organs of the chest cavity through a rib fracture and an incision in the pleura. This access allows surgeons to perform operations on the lungs, heart and other organs of the chest cavity.

History of the development of the method

The Troyanov method was developed in the early 20th century and was used to treat pulmonary tuberculosis. At that time, surgical treatment of tuberculosis was the only way to save the patient's life in severe cases of the disease. However, the methods of that time were extremely dangerous and often led to the death of patients. Troyanov proposed a new method of accessing the lungs through a rib fracture and a pleural incision, which made it possible to perform operations without the risk of damaging other organs of the chest cavity.

Application of the method in modern medicine

Today, the Troyanov method is still used to treat pulmonary tuberculosis, although the technology and instruments used in this method have changed significantly. This method can also be used to perform other operations on the chest organs, such as removing tumors and cutting adhesions.

However, the Troyanov method is not safe, and its use requires high qualifications and experience on the part of surgeons. If this method is used incorrectly, there may be a risk of damage to other organs of the chest cavity and the development of serious complications.

In conclusion, it can be noted that the Trojan transpleural approach is an important method of surgical intervention in the chest cavity, which was developed more than a hundred years ago. Today, this method is still used to treat pulmonary tuberculosis and other diseases, but its use requires high skill and experience on the part of surgeons.



Trinity transpleural is one of the new and little-known surgical interventions that has become available only recently. This is a surgical method for treating lung and thymus cancer, which was invented back in the 80s of the last century. However, its use was limited by a lack of equipment and the necessary qualifications of specialists, so this method was used only in isolated cases. With the development of technology and the improvement of devices for the treatment of diseases of the respiratory system and chest, this method has returned to widespread practice. **Trojan transpleural** therapy has found its place in the treatment of such serious diseases as lung cancer and thymus tumors.

A rare disease that patients encounter is a tumor of the thymus gland. In a healthy person, the thymus is responsible for immunity, but most often a tumor has to be treated already at the stages of development of the disease. Unfortunately, as soon as the tumor reaches a large size, it is already an operable stage. Most often, tumor treatment is at the stage of chemotherapy, radiation therapy, and only then surgery is performed. Surgical treatment may vary in complexity and duration, due to the location of the tumor and difficulty breathing. Surgery becomes possible only after the tumor volume has been reduced. Most cases during surgery related directly to the thymus gland